MedPath

TARO-TESTOSTERONE

TARO-TESTOSTERONE

Approved
DIN Number

02421186

Drug Class

Human

Market Date

Sep 2, 2014

Company
HC

Taro Pharmaceuticals Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02421186
AIG Number0120414001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule G (CDSA IV)
A
ATC Code
G03BA03 TESTOSTERONE
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification68:08.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

TESTOSTERONE UNDECANOATEActive
Strength: 40 MG
Monograph: TESTOSTERONE UNDECANOATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.